3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
24 24 0 1 0 0 0 0 0999 V2000
-0.9837 -1.3653 -1.2841 O 0 0 0 0 0 0 0 0 0 0 0 0
1.5215 -1.3744 0.6777 O 0 0 0 0 0 0 0 0 0 0 0 0
3.7441 -0.3579 -0.0469 O 0 0 0 0 0 0 0 0 0 0 0 0
0.2314 0.4638 0.1180 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.7423 -1.6203 0.1775 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0140 -0.0249 0.6949 C 0 0 1 0 0 0 0 0 0 0 0 0
-1.9172 1.2011 0.7620 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4288 2.0655 -0.3979 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0715 1.8153 -0.4126 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5557 -1.0650 -0.2391 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4250 -0.2329 0.2238 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6484 0.4951 -0.2733 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8339 -0.4775 1.6759 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.7406 1.7349 1.7041 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.9879 0.9904 0.6907 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.8767 1.7153 -1.3356 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.6776 3.1233 -0.2764 H 0 0 0 0 0 0 0 0 0 0 0 0
0.5031 1.8931 -1.4143 H 0 0 0 0 0 0 0 0 0 0 0 0
0.5953 2.5055 0.2576 H 0 0 0 0 0 0 0 0 0 0 0 0
2.7971 1.4181 0.2923 H 0 0 0 0 0 0 0 0 0 0 0 0
2.5693 0.7128 -1.3414 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.1875 -1.3611 1.0520 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.2089 -2.3302 -0.3772 H 0 0 0 0 0 0 0 0 0 0 0 0
3.6508 -1.1247 -0.6378 H 0 0 0 0 0 0 0 0 0 0 0 0
1 10 2 0 0 0 0
2 11 2 0 0 0 0
3 12 1 0 0 0 0
3 24 1 0 0 0 0
4 6 1 0 0 0 0
4 9 1 0 0 0 0
4 11 1 0 0 0 0
5 10 1 0 0 0 0
5 22 1 0 0 0 0
5 23 1 0 0 0 0
6 7 1 0 0 0 0
6 10 1 0 0 0 0
6 13 1 0 0 0 0
7 8 1 0 0 0 0
7 14 1 0 0 0 0
7 15 1 0 0 0 0
8 9 1 0 0 0 0
8 16 1 0 0 0 0
8 17 1 0 0 0 0
9 18 1 0 0 0 0
9 19 1 0 0 0 0
11 12 1 0 0 0 0
12 20 1 0 0 0 0
12 21 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
(2S)-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide
4.2 InChl
InChI=1S/C7H12N2O3/c8-7(12)5-2-1-3-9(5)6(11)4-10/h5,10H,1-4H2,(H2,8,12)/t5-/m0/s1
4.3 InChlKey
LXCXYTPSNJOTPN-YFKPBYRVSA-N
4.4 Canonical SMILES
C1CC(N(C1)C(=O)CO)C(=O)N
4.5 lsomeric SMILES
C1C[C@H](N(C1)C(=O)CO)C(=O)N
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病